Dimopoulos Christos 4
4 · Bunge Global SA · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Dimopoulos Christos
EVP and CSO
Transactions
- Exercise/Conversion
Common Stock
2025-11-21$50.07/sh+5,300$265,371→ 129,836.808 total - Exercise/Conversion
Stock Options (Right to buy)
2025-11-21−5,300→ 0 totalExercise: $50.07Exp: 2026-03-01→ Common Stock (5,300 underlying) - Sale
Common Stock
2025-11-21$94.38/sh−5,300$500,226→ 124,536.808 total - Sale
Common Stock
2025-11-21$94.37/sh−20,000$1,887,418→ 104,536.808 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $94.30 to $94.48. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- [F2]This transaction was executed in multiple trades at prices ranging from $94.28 to $94.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Global SA, any security holder of Bunge Global SA, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- [F3]This option became exercisable in three equal annual installments beginning on March 1, 2017.